Bio ReFine™, a pioneer in interventional structural cardiology, has reached a significant milestone with the successful first-in-human use of its Coriofix™ system for mitral valve repair.
This innovative, implant-less annuloplasty solution represents a transformative advancement in the treatment of mitral regurgitation.
The Coriofix™ system simplifies procedures and minimizes risks through its minimally invasive, fully endovascular approach. It enhances safety, delivers improved outcomes, and expands treatment options for patients who were previously ineligible for care
